https://www.medscape.com/viewarticle/971488
0
0
4/3/22 at 7:16pm
Organization
Medscape
Author
Sue Hughes
26 words
0
Comments
An investigational antisense oligonucleotide drug targeting a novel cholesterol pathway showed disappointing results in this phase 2b study.
You are the first to view
Create an account
or login to join the discussion